Study of Erlotinib in Combination With Bortezomib

Clinical trial NCT00895687 · COMPLETED

Trial details

NCT number: NCT00895687
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer

Start date: 2009-04-01
Primary completion: 2015-07-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.